The present invention generally relates to a hemostatic device.
As one of catheter procedures, a procedure is known in which various medical elongated bodies are introduced into a blood vessel of a limb such as an arm or hand of a patient through a puncture site formed by puncturing the blood vessel to perform treatment and therapy on a lesion site. For example, U.S. Patent Application Publication No. 2019/0133602 discloses a hemostatic device for hemostasis on a puncture site formed to enable access to a blood vessel (including a distal radial artery) running in a hand.
The hemostatic device in U.S. Patent Application Publication No. 2019/0133602 includes: a pressing member that applies a compressive force to a puncture site (hereinafter, also simply referred to as a “puncture site”) formed in a hand of a patient; a band body that secures the pressing member to the hand of the patient; and a support member that is disposed on the band body and presses the pressing member against the hand of the patient. In addition, the band body includes a first band body disposed between fingers of the patient and a second band body wrapped at a position on a forearm side of the hand of the patient.
An operator such as a doctor (hereinafter referred to as an “operator”) may set the puncture site at a predetermined position avoiding a metacarpal bone of an index finger of the hand and a metacarpal bone of a thumb of the hand when forming the puncture site on the hand. By setting the puncture site at such a predetermined position, the operator can prevent a puncture device such as an indwelling needle from interfering with the metacarpal bone of each finger when forming the puncture site.
However, in a case where the puncture site is formed at the predetermined position avoiding the metacarpal bone of the index finger and the metacarpal bone of the thumb, when hemostasis is performed using the hemostatic device described in U.S. Patent Application Publication No. 2019/0133602, the following problems occur.
The operator disposes the pressing member and the support member of the hemostatic device in the above-described U.S. application publication so as to overlap the puncture site when the hemostasis is performed on the puncture site.
When the operator disposes the hemostatic device in the above-identified U.S. application publication on the hand of the patient, the support member may be placed on the metacarpal bone of the index finger and the metacarpal bone of the thumb. In the hemostatic device in the above-identified U.S. application publication, when the second band body is wrapped around the hand of the patient in a state where the support member is disposed on the hand of the patient as described above, a gap is formed between the pressing member and the hand, and the second band body does not fit along an outer periphery of the hand of the patient. In such a state, the pressing member and the support member can be firmly secured to the hand of the patient by strongly tightening the first band body of the hemostatic device in the above-identified U.S. application publication. Meanwhile, in such a case, since it is necessary to strongly tighten the first band body of the hemostatic device in the above-identified U.S. application publication, pain may occur in the patient. Therefore, in the hemostatic device in the above-identified U.S. application publication, when the first band body cannot be strongly tightened due to pain or the like of the patient, the support member is disposed in a state of being inclined in a direction approaching a body surface of the hand from a fingertip side of the hand toward the forearm side. In the hemostatic device in the above-identified U.S. application publication, when the support member is disposed as described above, the pressing member cannot apply a compressive force to the puncture site in a vertical direction. Accordingly, the hemostatic device in the above-identified U.S. application publication cannot effectively apply the compressive force to the puncture site.
The hemostatic device disclosed here is capable of effectively applying a compressive force to a puncture site formed at a predetermined position avoiding a metacarpal bone of an index finger of a hand and a metacarpal bone of a thumb of the hand even when hemostasis is performed on the puncture site.
A hemostatic device according to one aspect includes: a support member configured to cover a puncture site formed in a patient; a securing member configured to secure the support member to the puncture site of the patient; and a pressing member connected to the support member and configured to compress the puncture site of the patient, in which the support member includes an upper end portion that is located on a distal side of the pressing member and forms an end portion of the support member, a lower end portion that is located on a proximal side of the pressing member and forms an end portion on a side opposite to the upper end portion, and a side surface portion that connects the upper end portion and the lower end portion, the support member has rigidity higher than that of the pressing member, the securing member includes a first band body portion configured to be disposed between fingers of the patient and extending in a first direction, and a second band body portion extending in a second direction different from the first direction, the support member is configured such that a width of the support member becomes shorter from the upper end portion toward the lower end portion and a thickness of the side surface portion becomes thinner from the upper end portion toward the lower end portion, the first band body portion extends in the first direction from the upper end portion side, and the second band body portion extends in the second direction from the side surface portion side.
The above hemostatic device includes the support member having rigidity higher than that of the pressing member. The support member is disposed so as to cover the puncture site together with the pressing member when hemostasis is performed on the puncture site formed at a predetermined position avoiding a metacarpal bone of an index finger of a hand of a patient and a metacarpal bone of a thumb of the hand of the patient. The support member can prevent the pressing member from lifting from the hand of the patient by pressing the pressing member against the hand of the patient. In addition, the width of the support member becomes shorter from the upper end portion toward the lower end portion. Therefore, when the support member is disposed on the hand of the patient, the support member can be disposed along the metacarpal bone of the index finger and the metacarpal bone of the thumb. Therefore, in the above hemostatic device, the second band body portion can be firmly wrapped along an outer periphery of the hand of the patient. In addition, in the support member, the thickness of the side surface portion becomes thinner from the upper end portion toward the lower end portion. In addition, the first band body portion configured to be disposed between fingers of the patient is configured to extend from the upper end portion side of the support member and press the upper end portion side of the support member against the hand of the patient. Therefore, the pressing member can apply a force to one end portion of the support member when the hemostasis starts in a state where the hemostatic device is attached to the hand of the patient. The one end portion side of the support member is lifted by the force applied by the pressing member. Accordingly, the support member is disposed such that a lower surface of the support member is substantially parallel to a body surface of the hand of the patient. Therefore, in the hemostatic device, the compressive force of the pressing member can be directed in a direction perpendicular to the puncture site by securing the first band body portion and the second band body portion to the hand of the patient in a state where the pressing member and the support member are disposed at the puncture site. Accordingly, the hemostatic device can effectively apply the compressive force to the puncture site.
According to another aspect, a hemostatic device securable to a hand of a patient comprises: a covering portion positionable in overlying relation to a puncture site on the hand of the patient when the hemostatic device is secured to the hand of the patient, with the covering portion including an inner surface configured to face toward the patient's hand when the hemostatic device is secured to the hand of the patient. A first band body portion and a second band body portion are provided for securing the covering portion to the patient's hand, with the first band body portion being fixed to the covering portion, extending away from a first part of the covering portion in a first direction of extent and configured to be positioned between fingers of the patient's hand, and the second band body portion being fixed to the covering portion and extending away from a second part of the covering portion in a second direction of extent different from the first direction of extent, wherein the first part of the covering portion is spaced from the second part of the covering portion. A pressing member is expandable to apply a compressive force to the puncture site when the hemostatic device is secured to the hand of the patient, with the covering portion overlying the pressing member. A support member is positioned between the covering portion and the pressing portion so that the covering member overlies the support member and the support member overlies the pressing member, with the support member being more rigid than the pressing member. The support member includes a first end portion and a second end portion that are disposed at opposite sides of the support member in a plan view of the support member, with the first end portion of the support member facing towards the first part of the covering portion and being located closer to the first part of the covering portion than the second end portion of the support member, and the second end portion of the support member facing away from the first part of the covering portion. The thickness of the first end portion of the support member is greater than the thickness of the second end portion of the support member.
In accordance with another aspect, a method comprises: positioning an expandable pressing member on a patient's hand, wherein a covering portion is positioned in overlying relation to the pressing member with a first band body portion, a second band body portion and a third band body portion fixed to the covering portion and extending away from the covering portion in different directions. The first band body portion, the second band body portion and the third band body portion each include a first surface and a second surface that face in opposite directions, with the first surfaces of the first band body portion, the second band body portion and the third band body portion facing in a common direction when the hemostatic device is laid flat. The second surfaces of the first band body portion, the second band body portion and the third band body portion facing in a common direction when the hemostatic device is laid flat. The first surface of the first band body portion and the second band body portion each include a securing portion, and the second surface of the second band body portion and the second surface of the third band body portion each include a securing portion. The securing portion on the second surface of the third band body portion includes first and second branch portions that are spaced apart from one another along at least a portion of a longitudinal extent of the first and second branch portions of the securing portion. The method additionally comprises positioning the pressing member in overlaying relation to either a first puncture site of the patient's hand or a second puncture site of the patient's hand, with the second puncture site being spaced from the first puncture site, and securing the pressing portion and the covering portion to the patient's hand. The securing of the pressing portion and the covering portion to the patient's hand comprises: wrapping the third band body portion and the second band body portion around a portion of the patient's hand and mating the securing portion on the first surface of the second band body portion with the first branch portion of the securing portion on the second surface of the third band body portion when the pressing member is positioned in overlaying relation to the first puncture site of the patient's hand, or wrapping the third band body portion and the second band body portion around a portion of the patient's hand and mating the securing portion on the first surface of the second band body portion with the second branch portion of the securing portion on the second surface of the third band body portion when the pressing member is positioned in overlaying relation to the second puncture site of the patient's hand; and positioning the first band body portion between two fingers of the patient's hand and mating the securing portion on the first surface of the first band body portion with the securing portion on the second surface of the second band body portion.
Hereinafter, embodiments of the hemostatic device, representing examples of the new hemostatic device disclosed here, will be described with reference to the accompanying drawings. The following description does not limit the technical scope or the meaning of terms described in the claims. Further, dimensional ratios in the drawings are exaggerated for convenience of description and may differ from actual ratios.
For example, as illustrated in
A specific position of the puncture site, which is a hemostasis target of the hemostatic device 100, is not particularly limited, and in the present embodiment, the following first puncture site p1, second puncture site p2, third puncture site p3, and fourth puncture site p4 are exemplified.
As illustrated in
In addition, the first puncture site p1 is located at a predetermined position between a metacarpal bone B1 of an index finger and a metacarpal bone B2 of a thumb and avoiding the metacarpal bone B1 of the index finger and the metacarpal bone B2 of the thumb. The snuff box is a cavity in the hand located near the radius when the patient spreads the thumb of the hand H.
As illustrated in
As illustrated in
As illustrated in
In the description below, the first puncture site p1 formed on the right hand H1 of the patient is also simply referred to as a “first puncture site p1”, and the second puncture site p2 formed on the right hand H1 of the patient is also simply referred to as a “second puncture site p2”. The third puncture site p3 formed on the left hand H2 of the patient is also simply referred to as a “third puncture site p3”, and the fourth puncture site p4 formed on the left hand H2 of the patient is also simply referred to as a “fourth puncture site p4”.
Hereinafter, the hemostatic device 100 will be described in detail.
<Hemostatic Device>
In brief, as illustrated in
<Pressing Member>
For example, as illustrated in
The inflatable member 180 is constituted by, for example, a single film-like or film-shaped member formed in a bag shape so as to include the lumen 183.
However, the inflatable member 180 may be formed by joining edge portions of two sheet-like or sheet-shaped film materials in a state where the lumen 183 is formed between the two sheet-like film materials formed in a substantially rectangular shape.
The inflatable member 180 is inflated by supply of a fluid such as air to the lumen 183, and contracts by discharging the fluid supplied to the lumen 183.
The film materials for the inflatable member 180 can be, for example, a resin material having a predetermined thickness. A tube 203 (see
A material for the film-like member constituting the inflatable member 180 is not particularly limited, and examples thereof include polyvinyl chloride, polyolefin such as polyethylene, polypropylene, polybutadiene, or ethylene-vinyl acetate copolymer (EVA), polyester such as polyethylene terephthalate (PET) or polybutylene terephthalate (PBT), polyvinylidene chloride, silicone, polyurethane, various thermoplastic elastomers such as polyamide elastomer, polyurethane elastomer, and polyester elastomer, nylon, nylon elastomer, or any combination thereof (e.g., blended resin, polymer alloy, laminate, etc.).
As illustrated in
The inner surface 130a of the covering portion 130 is a surface disposed on a body surface side of the right hand H1 of the patient when the hemostatic device 100 is attached to the right hand H1 of the patient (see
As illustrated in
The connection member 190 is disposed so as to form a space 191 between the connection member 190 and the covering portion 130. The support member 110 is disposed in the space 191.
The connection member 190 can be constituted of, for example, a resin member. An outer peripheral edge of the connection member 190 can be connected to the covering portion 130 by, for example, the adhesive or the welding.
The inflatable member 180 has a circular shape in plan views illustrated in
As illustrated in
As illustrated in
In the marker portion 185, for example, the entire marker portion 185 can be formed of a colored rectangular marker. A specific shape, a color, a formation method, and a position formed in the inflatable member 180 of the marker portion 185 are not particularly limited. For example, the marker portion 185 may include a transparent central portion and a colored linear frame portion surrounding the central portion.
<Support Member>
As illustrated in
The “distal side of the inflatable member 180” means an end portion side (upper side in
As illustrated in
In addition, as illustrated in
The lower surface 110a of the support member 110 is a surface on which the inflatable member 180 is disposed, and the upper surface 110b is a surface on which the covering portion 130 is disposed.
As illustrated in
As illustrated in
In the hemostatic device 100, a portion of the inflatable member 180 where the marker portion 185 is provided, a portion of the connection member 190 overlapping the marker portion 185, and a portion of the covering portion 130 overlapping the marker portion 185 can be formed to be transparent. In a case where the members 130, 180, and 190 are configured in this way, when the hemostatic device 100 is attached to the right hand H1 of the patient as illustrated in
The support member 110 can be constituted of a member having rigidity higher than that of the inflatable member 180. With such a configuration, as illustrated in
When the inflatable member 180 is constituted of the above-described materials, examples of the constituent materials of the support member 110 include an acrylic resin, polyvinyl chloride (in particular, hard polyvinyl chloride), polyolefin such as polyethylene, polypropylene, and polybutadiene, polystyrene, poly-(4-methylpentene-1), polycarbonate, ABS resin, polymethyl methacrylate (PMMA), polyacetal, polyacrylate, polyacrylonitrile, polyvinylidene sulfoxide, ionomer, acrylonitrile-butadiene-styrene copolymer, polyethylene terephthalate (PET), or the like.
<Securing Member>
As illustrated in
The covering portion 130 constitutes a main body portion to which the band body portions 140, 150, and 160 are connected. As illustrated in
In the securing member 120, the covering portion 130 and the band body portions 140, 150, and 160 may be integrally configured, or members configuring the band body portions 140, 150, and 160 may be connected to a member configuring the covering portion 130. In addition, the securing member 120 may not include the covering portion 130, and the band body portions 140, 150, and 160 may be directly connected to the support member 110.
The first band body portion 140 is configured to be disposed between fingers of the patient. The first band body portion 140 extends in a predetermined first direction.
As illustrated in
For example, as illustrated in
The second band body portion 150 extends in a second direction different from the first direction that is an extending direction of the first band body portion 140. Specifically, as illustrated in
As illustrated in
The third band body portion 160 extends in a third direction different from the first direction that is the extending direction of the first band body portion 140 and from the second direction that is an extending direction of the second band body portion 150. Specifically, as illustrated in
As illustrated in
As illustrated in
Constituent materials from which the band body portions 140, 150, and 160 may be fabricated are not particularly limited, and may include, for example, a vinyl chloride resin, a polyurethane resin, a polyester resin, or the like. In addition, a shape, a length, a thickness, and the like of each of the band body portions 140, 150, and 160 are not particularly limited.
As illustrated in
As illustrated in
As illustrated in
The first securing site 171 and the second securing site 172 are configured as a male side of a surface fastener. The third securing site 173 and the fourth securing site 174 are configured as a female side of the surface fastener. The surface fastener in the present specification is a fastener that is attachable and removable in terms of surface, and is, for example, Magic Tape (registered trademark) or Velcro (registered trademark).
The main body portion 155 of the second band body portion 150 and the main body portion 165 of the third band body portion 160 are configured to be attachable and removable via the third securing site 173 and the second securing site 172. In addition, the main body portion 145 of the first band body portion 140 and the main body portion 155 of the second band body portion 150 are configured to be attachable and removable via the first securing site 171 and the fourth securing site 174.
As illustrated in
Specific structures of the securing sites 171, 172, 173, and 174 are not limited as long as the support member 110 and the inflatable member 180 can be secured to the right hand H1 of the patient by connecting the band body portions 140, 150, and 160 to each other in a state where the hemostatic device 100 is disposed on the right hand H1 of the patient. For example, installation of some of the securing sites can be omitted, and positions where the securing sites are disposed on the band body portions 140, 150, and 160, and the like can be freely changed. In addition, when each of the securing sites 171, 172, 173, and 174 includes the surface fastener, the male side and the female side of the surface fastener may be interchanged. In addition, each of the securing sites 171, 172, 173, and 174 may include, for example, a snap, a button, a clip, a coupling mechanism including a frame portion in which a hole or a projection is formed and an engaged portion in which a hole engageable with the frame portion is formed, or the like.
<Injection Portion>
As illustrated in
The injection portion 201 includes a connector having an incorporated check valve (not illustrated). A syringe (not illustrated) can be connected to the injection portion 201.
A cushioning member 202 having an inflatable space is disposed between the injection portion 201 and the inflatable member 180. The cushioning member 202 includes a flexible bag-shaped member having a space formed inside. The cushioning member 202 may be provided with an arrow-shaped marker indicating a direction in which the syringe is inserted into the injection portion 201.
The injection portion 201 is connected to one end side of the cushioning member 202. A lumen of the injection portion 201 communicates with the space in the cushioning member 202. When the check valve incorporated in the injection portion 201 is closed, communication between the lumen of the injection portion 201 and the space of the cushioning member 202 is cut off.
A flexible tube 203 is connected to the other end side of the cushioning member 202. A lumen of the tube 203 communicates with the space of the cushioning member 202. In addition, the other end portion of the tube 203 which is opposite to one end portion connected to the cushioning member 202 is connected to the inflatable member 180. The lumen of the tube 203 communicates with the lumen 183 of the inflatable member 180.
To inflate the inflatable member 180, the operator inserts a distal tubular portion of a syringe (not illustrated) into the injection portion 201 to open the check valve. The operator injects air in the syringe into the lumen 183 of the inflatable member 180 by pushing a plunger of the syringe in a state where the check valve of the injection portion 201 is open.
When the air is injected into the lumen 183 of the inflatable member 180, the inflatable member 180 is inflated. When the inflatable member 180 is inflated, the cushioning member 202 communicating with the lumen 183 of the inflatable member 180 via the tube 203 expands. The operator can easily understand that the inflatable member 180 is inflated without leakage of air by visually confirming expansion of the cushioning member 202.
To contract the inflatable member 180, the operator inserts the distal tubular portion of the syringe into the injection portion 201 and pulls the plunger of the syringe. By performing the above operation, the operator can discharge the air in the lumen 183 of the inflatable member 180 to the syringe.
The injection portion 201, the cushioning member 202, and the tube 203 may be prepared and provided in a state of being coupled to the inflatable member 180, or may be prepared and provided in a state of being separated from the inflatable member 180.
<Usage Examples of Hemostatic Device>
Next, a first usage example of the hemostatic device 100 will be described with reference to
In the first usage example, a use procedure of the hemostatic device 100 when the hemostasis is performed on the first puncture site p1 formed on the right hand H1 of the patient illustrated in
When the hemostatic device 100 is attached to the right hand H1 of the patient, as illustrated in
When the hemostatic device 100 is attached to the right hand H1 of the patient, the operator disposes the support member 110 so that the support member 110 overlaps the metacarpal bone B1 of the index finger and the metacarpal bone B2 of the thumb. As illustrated in
As illustrated in
When the hemostasis is performed on the first puncture site p1, the operator can connect the third securing site 173 disposed on the inner surface of the second band body portion 150 to the second branch portion 172b of the second securing site 172. The first puncture site p1 is located on a fingertip side of the right hand H1 of the patient than the second puncture site p2 (see
In addition, the second securing site 172 is disposed in the main body portion 165 of the third band body portion 160. Therefore, a part of the main body portion 165 is between the second securing site 172 and the one end portion 161 of the third band body portion 160. When the operator wraps the third band body portion 160 around the right hand H1 of the patient, by pulling the main body portion 165 using the one end portion 161 of the third band body portion 160 as a base point, the first branch portion 172a not used for connecting the second band body portion 150 and the third band body portion 160 can be prevented from being lifted from the right hand H1 of the patient.
For the above reasons, when the operator connects the second band body portion 150 and the third band body portion 160 via the second branch portion 172b, the lifting of the first branch portion 172a can be prevented (see
It is also possible to adopt a configuration in which the third band body portion 160 itself is divided into a plurality of portions, and each of the portions of the third band body portion 160 is provided with a separate second securing site 172 (see
As illustrated in
The support member 110 has a substantially triangular shape having three sides. The hemostatic device 100 includes three band body portions 140, 150, and 160 disposed to extend from each side of the support member 110. Therefore, the hemostatic device 100 can secure the support member 110 to the right hand H1 of the patient in a state in which a uniform force is applied to each side of the support member 110 by connecting the band body portions 140, 150, and 160 to each other.
In addition, the support member 110 has a shape bilaterally symmetrical with respect to the long axis C of the first band body portion 140. Therefore, the hemostatic device 100 can uniformly apply a force along a left-right direction to the support member 110 by wrapping the band body portions 150 and 160 extending in the left-right direction based on the first band body portion 140 around the right hand H1 of the patient. Accordingly, the hemostatic device 100 can prevent positional deviation of the support member 110 in a state where the support member 110 is disposed on the right hand H1 of the patient.
The operator inflates the inflatable member 180 by injecting air into the inflatable member 180 in a state where the syringe is connected to the injection portion 201. In the hemostatic device 100, as illustrated in
When the inflatable member 180 is inflated in a state where the hemostatic device 100 is attached to the right hand H1 of the patient, the support member 110 presses the inflatable member 180 against the right hand H1 of the patient. Accordingly, the hemostatic device 100 can prevent the inflatable member 180 from lifting from the right hand H1 of the patient.
When performing hemostasis using the hemostatic device 100, the operator can more strongly tighten the first band body portion 140 disposed in the inter-finger portion fb so as to increase a securing force of the support member 110 with respect to the right hand H1 of the patient. By tightening the first band body portion 140 as described above, the operator can firmly secure the support member 110 to the right hand H1 of the patient even when the support member 110 is disposed in an unstable state on the right hand H1 of the patient. When the first band body portion 140 is strongly tightened as described above, pain may occur in the patient. Therefore, when the first band body portion 140 cannot be strongly tightened due to pain or the like of the patient, the hemostatic device 100 may be disposed such that the lower surface 110a of the support member 110 is inclined with respect to the body surface of the right hand H1 of the patient.
To solve the above problem, the hemostatic device 100 is configured such that the thickness of the side surface portion 113 of the support member 110 becomes thinner from the upper end portion 111 toward the lower end portion 112. In addition, the first band body portion 140 configured to be disposed in the inter-finger portion fb located between the fingers of the patient extends from the upper end portion 111 side of the support member 110, and is configured to press the upper end portion 111 side of the support member 110 against the right hand H1 of the patient. Therefore, when the inflatable member 180 starts inflating in the state where the hemostatic device 100 is attached to the right hand H1 of the patient, the inflatable member 180 applies a force to the upper end portion 111 of the support member 110. The upper end portion 111 side of the support member 110 is lifted by the force applied by the inflatable member 180. Accordingly, as illustrated in
The corner portions 115a, 115b, and 115c of the support member 110 have the rounded shape (see
According to the above procedures, the operator can perform the hemostasis on the first puncture site p1 formed in the right hand H1 of the patient using the hemostatic device 100.
Next, a second usage example to a fourth usage example of the hemostatic device 100 will be described with reference to
When the hemostasis is performed on the second puncture site p2, the operator connects the second band body portion 150 and the third band body portion 160 via the first branch portion 172a located on the fingertip side of the patient than the second branch portion 172b, thereby narrowing the range in which the right hand H1 of the patient is restrained by the band body portions 150 and 160.
The third usage example is a method of performing hemostasis on the third puncture site p3 formed on the left hand H2 of the patient using the hemostatic device 100. In the third usage example, the operator can connect the second band body portion 150 and the third band body portion 160 via the securing sites 172 and 173 by bringing the third securing site 173 (see
When the hemostasis is performed on the third puncture site p3, the operator connects the second band body portion 150 and the third band body portion 160 via the second branch portion 172b located on the forearm A side of the left hand H2 of the patient than the first branch portion 172a, thereby narrowing a range in which the left hand H2 of the patient is restrained by the band body portions 150 and 160.
The fourth usage example is a method of performing hemostasis on the fourth puncture site p4 formed on the left hand H2 of the patient using the hemostatic device 100. In the fourth usage example, the operator can connect the second band body portion 150 and the third band body portion 160 via the securing sites 172 and 173 by bringing the third securing site 173 (see
When the hemostasis is performed on the fourth puncture site p4, the operator connects the second band body portion 150 and the third band body portion 160 via the first branch portion 172a located on a fingertip side of the left hand H2 of the patient than the second branch portion 172b, thereby narrowing the range in which the left hand H2 of the patient is restrained by the band body portions 150 and 160.
As described above, the hemostatic device 100 according to present embodiment includes the support member 110 configured to cover the first puncture site p1, the securing member 120 configured to secure the support member 110 to the first puncture site p1, and the inflatable member 180 connected to the support member 110 and configured to compress the first puncture site p1. The support member 110 includes: the upper end portion 111 that is located on the distal side of the inflatable member 180 and forms the end portion of the support member 110; the lower end portion 112 that is located on the proximal side of the inflatable member 180 and forms the end portion of the side opposite to the upper end portion 111; and the side surface portion 113 that connects the upper end portion 111 and the lower end portion 112, and the support member 110 has rigidity higher than that of the inflatable member 180. The securing member 120 includes: the first band body portion 140 configured to be disposed between the fingers of the patient and extending in the first direction; and the second band body portion 150 extending in the second direction different from the first direction. The support member 110 is configured such that the width W of the support member 110 becomes shorter from the upper end portion 111 toward the lower end portion 112, and the thickness of the side surface portion 113 becomes thinner from the upper end portion 111 toward the lower end portion 112. The first band body portion 140 extends in the first direction from the upper end portion 111 side, and the second band body portion 150 extends in the second direction from the side surface portion 113 side.
The hemostatic device 100 configured as described above includes the support member 110 having rigidity higher than that of the inflatable member 180. The support member 110 is disposed so as to cover the first puncture site p1 together with the inflatable member 180 when the hemostasis is performed on the first puncture site p1 formed at a predetermined position avoiding the metacarpal bone B1 of the index finger of the right hand H1 of the patient and the metacarpal bone B2 of the thumb of the right hand H1 of the patient. The support member 110 can prevent the inflatable member 180 from being lifted from the right hand H1 of the patient by pressing the inflatable member 180 against the right hand H1 of the patient. In addition, the width W of the support member 110 becomes shorter from the upper end portion 111 toward the lower end portion 112. Therefore, when the support member 110 is disposed on the right hand H1 of the patient, the support member 110 can be disposed along the metacarpal bone B1 of the index finger and the metacarpal bone B2 of the thumb. Therefore, the second band body portion 150 can be firmly wrapped along the outer periphery of the right hand H1 of the patient. In addition, in the support member 110, the thickness of the side surface portion 113 becomes thinner from the upper end portion 111 toward the lower end portion 112. In addition, the first band body portion 140 configured to be disposed in the inter-finger portion fb located between the fingers of the patient extends from the upper end portion 111 side of the support member 110, and is configured to press the upper end portion 111 side of the support member 110 against the right hand H1 of the patient. Therefore, when the hemostasis is started in the state where the hemostatic device 100 is attached to the right hand H1 of the patient, the inflatable member 180 can apply a force to the upper end portion 111 of the support member 110. The upper end portion 111 side of the support member 110 is lifted by the force applied by the inflatable member 180. Accordingly, the support member 110 is disposed such that the lower surface 110a of the support member 110 is substantially parallel to the body surface of the right hand H1 of the patient. Therefore, in the hemostatic device 100, a compressive force of the inflatable member 180 can be directed in a direction perpendicular to the first puncture site p1 by securing the first band body portion 140 and the second band body portion 150 to the right hand H1 of the patient in a state where the inflatable member 180 and the support member 110 are disposed at the first puncture site p1. Accordingly, the hemostatic device 100 can effectively apply a compressive force to the first puncture site p1.
In addition, the support member 110 has an outer shape bilaterally symmetrical with respect to the long axis C of the first band body portion 140. That is, the outer shape of the support member 110 is bilaterally symmetric with respect to a plane containing the long axis C of the first band body portion 140 and perpendicular to the surfaces 110a, 110b of the support member 110.
In the hemostatic device 100 having the above configuration, since the support member 110 has the outer shape bilaterally symmetrical with respect to the long axis C of the first band body portion 140, a uniform tensile force can be applied to the support member 110 along the left-right direction by wrapping the band body portions 150 and 160 extending in the left-right direction based on the first band body portion 140 around the right hand H1 of the patient.
Accordingly, the hemostatic device 100 can prevent the positional deviation of the support member 110 in the state where the support member 110 is disposed on the right hand H1 of the patient.
In addition, the securing member 120 includes the third band body portion 160 extending in the third direction different from the first direction and the second direction. The third band body portion 160 extends in the third direction from the side surface portion 113 located on the side opposite to the second band body portion 150 with the support member 110 sandwiched therebetween. The third band body portion 160 includes: the one end portion 161 located on the support member 110 side; the other end portion 163 located on the side opposite to the one end portion 161; and the main body portion 165 extending between the one end portion 161 and the other end portion 163. The main body portion 165 includes the second securing site 172 configured to be attachable to and removable from the second band body portion 150. In the second securing site 172, the end portion located on the other end portion 163 side is branched into the plurality of portions 172a and 172b.
In the hemostatic device 100 configured as described above, when the third band body portion 160 is wrapped around the right hand H1 of the patient, by pulling the main body portion 165 using the one end portion 161 of the third band body portion 160 as a base point, the first branch portion 172a (or the second branch portion 172b) of the second securing site 172 not used for connecting the second band body portion 150 and the third band body portion 160 can be prevented from being lifted from the right hand H1 of the patient. In addition, when connecting the second band body portion 150 and the third band body portion 160, the operator can selectively connect the third securing site 173 disposed on the inner surface of the second band body portion 150 to the first branch portion 172a and the second branch portion 172b. Accordingly, when the hemostatic device 100 is attached to the right hand H1 of the patient, the hemostatic device 100 can narrow the range in which the band body portions 150 and 160 restrain the right hand H1 of the patient.
In addition, the corner portions 115a, 115b, and 115c located on the outer peripheral side surface of the support member 110 have the rounded shape.
Since the hemostatic device 100 has the above configuration, when the inflatable member 180 is inflated to apply a compressive force to the first puncture site p1, the hemostatic device 100 can prevent the corner portions 115a, 115b, and 115c of the support member 110 from biting into the right hand H1 of the patient.
The support member 110 has the hole 117 at a position overlapping the inflatable member 180.
Since the hemostatic device 100 has the above configuration, when the operator disposes the inflatable member 180 and the support member 110 in the first puncture site p1, the position of the marker portion 185 disposed in the inflatable member 180 can be visually confirmed through the hole 117 formed in the support member 110. Therefore, in the hemostatic device 100, the inflatable member 180 can be appropriately positioned at the first puncture site p1 based on the marker portion 185.
Next, a hemostatic device according to a modification of Embodiment 1 and a hemostatic device according to Embodiment 2 will be described. In the description below, features and aspects of the hemostatic device, the use procedure of the hemostatic device, and the like described in Embodiment 1 will not be repeated. In addition, contents that are not particularly described in the modification and Embodiment 2 may be the same as those in Embodiment 1.
<Modification>
A shape of the second securing site 172 disposed in the third band body portion 160 can be freely changed. For example, as illustrated in
As illustrated in
The third band body portion 160 extends in the third direction from the side surface portion 113 (see
The third band body portion 160 includes: the one end portion 161 located on the support member 110 side; the other end portion 163 located on the side opposite to the one end portion 161; and the main body portion 165 extending between the one end portion 161 and the other end portion 163.
The third band body portion 160 branches into a first portion 160a and a second portion 160b at the main body portion 165.
The second securing site 172 can be disposed in each of the first portion 160a and the second portion 160b.
In the hemostatic device 100A according to Embodiment 2, when connecting the second band body portion 150 and the third band body portion 160, the operator can selectively connect the third securing site 173 (see
Accordingly, in the hemostatic device 100A according to Embodiment 2, similarly to the hemostatic device 100 according to Embodiment 1, when the hemostatic device 100A is attached to the hand H of the patient, the range in which the band body portions 150 and 160 restrain the right hand H1 of the patient can be narrowed.
<Modification of Support Member>
Hereinafter, the modification of the support member will be described with reference to
As illustrated in
As illustrated in
In the support members 110B, 110C, 110D, and 110E illustrated in
The shape, the dimension, and the like of each part of the hemostatic device are not particularly limited, and may be appropriately changed as long as the hemostasis can be performed on the puncture site by the compress of the pressing member disposed at the puncture site.
The detailed description above describes embodiments of a hemostatic device and operational use representing examples of the new hemostatic device and method of use disclosed here. The invention is not limited, however, to the precise embodiments and variations described. Various changes, modifications and equivalents can be effected by one skilled in the art without departing from the spirit and scope of the invention as defined in the accompanying claims. It is expressly intended that all such changes, modifications and equivalents that fall within the scope of the claims are embraced by the claims.
Number | Date | Country | Kind |
---|---|---|---|
2021-057231 | Mar 2021 | JP | national |
This application is a continuation of International Patent Application No. PCT/JP2022/015311 filed on Mar. 29, 2022, which claims priority to Japanese Patent Application No. 2021-057231 filed on Mar. 30, 2021, the entire content of both of which is incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
Parent | PCT/JP2022/015311 | Mar 2022 | US |
Child | 18468222 | US |